Short chain fatty acids and colon motility in a mouse model of irritable bowel syndrome.
Ilnar F ShaidullovDina M SorokinaFarit G SitdikovAnton HermannSayar R AbdulkhakovGuzel F SitdikovaPublished in: BMC gastroenterology (2021)
Our data indicate that the increased transit rate in the mouse IBS model group is associated with a disbalance of activating and inhibiting action of SCFAs due to chronically elevated SCFA levels, which may impact the pathogenesis of IBS with predominant diarrhea syndrome.